PC945 Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients
Condition: Pulmonary Aspergillosis Interventions: Drug: PC945; Drug: Standard of Care Sponsor: Pulmocide Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2021 Category: Research Source Type: clinical trials
